Two-Step Pretargeted Nanotherapy for CD20 Crosslinking: Anti-Lymphoma

1 post / 0 new
Jon Moulton
Jon Moulton's picture
Two-Step Pretargeted Nanotherapy for CD20 Crosslinking: Anti-Lymphoma

Chu TW, Zhang R, Yang J, Chao MP, Shami PJ, Kopecek J. A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to Rituximab. Theranostics. 2015;5(8):834-46. doi:10.7150/thno.12040